00002-7502
                        
                    
                            Gemzar
                        
                    
                                    Gemcitabine hydrochloride
                                
                            
                        
                    
                            INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
                        
                    
                                    Intravenous
                                
                            
                        
                    
                                     Gemcitabine hydrochloride
                                
                                
                                     1.0
                                
                                
                                     g/25mL
                                
                                
                            
                        
                    
                                     00002-7502-01
                                
                                
                                     25 mL in 1 VIAL, SINGLE-DOSE (0002-7502-01) 
                                
                                
                                     May 22, 1996
                                
                                
                                    Chemotherapy
                                
                            
                        
                    
                                    Antimetabolite
                                
                            
                        
                    
                                    Pyrimidine Analog
                                
                            
                        
                    
                            In Use
                        
                     An official website of the United States government
 An official website of the United States government
		 Home
 Home 
                             
                    